Kim N. Green

Active 2001–2025

84
Papers
20,283
Citations
58
h-index
81
i10-index

Citations

Citations per year for Kim N. Green1992: 1 citations1994: 1 citations2001: 1 citations2002: 2 citations2003: 1 citations2004: 5 citations2005: 24 citations2006: 86 citations2007: 134 citations2008: 183 citations2009: 204 citations2010: 339 citations2011: 257 citations2012: 255 citations2013: 225 citations2014: 254 citations2015: 243 citations2016: 258 citations2017: 288 citations2018: 400 citations2019: 778 citations2020: 972 citations2021: 1,101 citations2022: 892 citations2023: 683 citations2024: 1,042 citations2025: 647 citations2026: 19 citations1993: no citations, so this year is not shown1995–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,115 citing papers, 30.2% of this breakdownChina: 1,236 citing papers, 12% of this breakdownUnited Kingdom: 572 citing papers, 5.6% of this breakdownGermany: 544 citing papers, 5.3% of this breakdownCanada: 410 citing papers, 4% of this breakdownItaly: 353 citing papers, 3.4% of this breakdownJapan: 304 citing papers, 3% of this breakdownAustralia: 270 citing papers, 2.6% of this breakdownSpain: 262 citing papers, 2.5% of this breakdownFrance: 253 citing papers, 2.5% of this breakdownIndia: 239 citing papers, 2.3% of this breakdownSouth Korea: 235 citing papers, 2.3% of this breakdown
0%30.2%Other 24.3%

Fields

  • Medicine43.3%
  • Neuroscience34.9%
  • Biochemistry, Genetics and Molecular Biology15.2%
  • Immunology and Microbiology2.1%
  • Nursing1.3%
  • Computer Science0.6%
  • Other2.6%

Topics

  • Alzheimer's disease research and treatments14.7%
  • Neuroinflammation and Neurodegeneration Mechanisms12.2%
  • Tryptophan and brain disorders3.7%
  • Neuroscience and Neuropharmacology Research3.5%
  • Cholinesterase and Neurodegenerative Diseases3.4%
  • Immune cells in cancer2.9%
  • Other59.6%

Coauthors

All papers

Open in search
  1. Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain

    Authors: , , , , , , , , , , - Neuron 2014 cited by 2,030

  2. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 998

  3. Intracellular amyloid-β in Alzheimer's disease

    Authors: , , - Nature reviews. Neuroscience 2007 cited by 1,932

  4. Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology

    Authors: , , , , , , , - Brain 2016 cited by 737

  5. Necroptosis activation in Alzheimer's disease

    Authors: , , , , , , , , , , , , - Nature Neuroscience 2017 cited by 494

  6. Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain

    Authors: , , , , , - EBioMedicine 2020 cited by 278

  7. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice

    Authors: , , , , , , , - Journal of Neuroinflammation 2015 cited by 525

  8. To Kill a Microglia: A Case for CSF1R Inhibitors

    Authors: , , - Trends in Immunology 2020 cited by 281

  9. Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Frontiers in Neuroscience 2022 cited by 212

  10. Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice

    Authors: , , , , - Neuron 2005 cited by 1,294

  11. Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models

    Authors: , - Brain Behavior and Immunity 2016 cited by 364

  12. Replacement of microglia in the aged brain reverses cognitive, synaptic, and neuronal deficits in mice

    Authors: , , , , , , , , , , - Aging Cell 2018 cited by 394

  13. Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease

    Authors: , , , , - Journal of Neuroscience 2005 cited by 689

  14. Microglia as hackers of the matrix: sculpting synapses and the extracellular space

    Authors: , , , - Cellular and Molecular Immunology 2021 cited by 171

  15. Microglia Elimination Increases Neural Circuit Connectivity and Activity in Adult Mouse Cortex

    Authors: , , , , , - Journal of Neuroscience 2020 cited by 166

  16. Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau

    Authors: , , , , , , - Journal of Neuroscience 2008 cited by 402

  17. Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease

    Authors: , , , , , - Brain 2019 cited by 165

  18. Microglial repopulation resolves inflammation and promotes brain recovery after injury

    Authors: , , , , , - Glia 2017 cited by 230

  19. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 869

  20. Glucocorticoids Increase Amyloid-β and Tau Pathology in a Mouse Model of Alzheimer’s Disease

    Authors: , , , , - Journal of Neuroscience 2006 cited by 614

  21. A Trem2R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Neurodegeneration 2023 cited by 50

  22. Elimination of microglia improves cognitive function following cranial irradiation

    Authors: , , , , , , , , , , , , - Scientific Reports 2016 cited by 270

  23. Microglia promote anti-tumour immunity and suppress breast cancer brain metastasis

    Authors: , , , , , , , , , , , , , , , , , - Nature Cell Biology 2023 cited by 56

  24. Aβ inhibits the proteasome and enhances amyloid and tau accumulation

    Authors: , , , , - Neurobiology of Aging 2007 cited by 376